Vertex Pharmaceuticals Inc (MIL:1VRTX)
€ 436.75 0 (0%) Market Cap: 114.49 Bil Enterprise Value: 109.92 Bil PE Ratio: 0 PB Ratio: 7.74 GF Score: 72/100

Q2 2023 Vertex Pharmaceuticals Inc Earnings Call Transcript

Aug 01, 2023 / 08:30PM GMT
Operator

Good afternoon, and welcome to the Vertex Pharmaceuticals Second Quarter 2023 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Susie Lisa, Senior Vice President, Investor Relations. Please go ahead.

Susie Lisa
Vertex Pharmaceuticals Incorporated - SVP of IR

Good evening, everyone. My name is Susie Lisa, and as the Senior Vice President of Investor Relations, it is my pleasure to welcome you to our second quarter 2023 financial results conference call. On tonight's call making prepared remarks we have Dr. Reshma Kewalramani, Vertex's CEO and President; Stuart Arbuckle, Chief Operating Officer; and Charlie Wagner, Chief Financial Officer. We recommend that you access the webcast slides as you listen to this call. The call is being recorded, and a replay will be available on our website.

We will make forward-looking statements on this call that are subject to the risks and uncertainties discussed in detail in today's press release and in our filings with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot